Lab Members

    Group Leader

    Daniel Abankwa, PhD, Affiliated Group Leader
    Adjunct Professor at Åbo Akademi University
    Professor of Cancer Cell Biology at the University of Luxembourg
    Research Gate / ORCiD / LinkedIn

    Contact Information

    Email: daniel.abankwa [at]
    Email: daniel.abankwa [at]
    Phone: (+352) 46 66 44 6897

    Laboratory Manager

    Christina Oetken-Lindholm

    Postdoctoral Researcher

    Abankwa Lab, office 4138

    +358 (0)29 450 3785 / 3779

    christina.oetken-lindholm [at]


    • Postdoctoral researcher at Turku Center for Biotechnology since January 2012
    • PhD in cell biology Åbo Akademi University 1995
    • MSc in cell biology, Åbo Akademi University 1990

    Project involvement

    Development of K-ras targeted breast cancer drugs

    Research interests

    Drug development for cancer treatment, breast- and prostate cancer

    Senior and Postdoctoral Researchers

    Alexandros Kiriazis

    Postdoctoral Researcher

    Abankwa Lab, Helsinki

    alexandros.kiriazis [at]

    Hanna Parkkola

    Postdoctoral Researcher

    Pentikäinen Lab, office 5088

    +358 29 450 3785 / 3779

    hanna.parkkola [at]


    • Postdoctoral Researcher at Turku Bioscience, Molecular Mechanisms of Diseases Group (Pentikäinen Lab), since 2020
    • Postdoctoral Researcher at Turku Bioscience, Ras Drug Discovery Group (Abankwa Lab), 2018 - 2019
    • PhD in Nanosciences, University of Barcelona, 2014
    • MSc in Drug Development, University of Turku, 2007

    Research Interests

    Drug discovery and development, drug delivery, translational cancer research 

    Doctoral Candidates

    Farid Ahmad Siddiqui

    Doctoral Candidate

    Abankwa Lab, office 5130

    +358 (0)29 450 3779 / 3779

    farid.siddiqui [at]


    • Doctoral student at Turku Center for Biotechnology since February 2016
    • MSc in Biotechnology form Punjab Technical University and master thesis form School of Life Sciences, Jawaharlal Nehru University, New Delhi, India, 2011

    Project involvement

    CIMO project- Understanding the mechanism of action of conglobatin A in blocking oncogenic K-ras signaling

    Research interests

    Drug development especially inhibiting oncogenic K-ras